cangrelor

Generic: cangrelor

Labeler: gland pharma limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cangrelor
Generic Name cangrelor
Labeler gland pharma limited
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

cangrelor 50 mg/1

Manufacturer
Gland Pharma Limited

Identifiers & Regulatory

Product NDC 68083-412
Product ID 68083-412_706b6332-5afe-498b-a846-788e6ebc6823
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA213551
Listing Expiration 2026-12-31
Marketing Start 2025-08-11

Pharmacologic Class

Established (EPC)
p2y12 platelet inhibitor [epc]
Mechanism of Action
p2y12 receptor antagonists [moa]
Physiologic Effect
decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68083412
Hyphenated Format 68083-412

Supplemental Identifiers

RxCUI
1656056
UNII
6AQ1Y404U7
NUI
N0000182142 N0000008832 N0000182143

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cangrelor (source: ndc)
Generic Name cangrelor (source: ndc)
Application Number ANDA213551 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 10 VIAL, SINGLE-DOSE in 1 CARTON (68083-412-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

68083-412-10 10 VIAL, SINGLE-DOSE in 1 CARTON (68083-412-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE

Ingredients (1)

cangrelor (50 mg/1)

Linked Drug Pages (1)

Cangrelor ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "706b6332-5afe-498b-a846-788e6ebc6823", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143"], "unii": ["6AQ1Y404U7"], "rxcui": ["1656056"], "spl_set_id": ["c86264c2-ef49-4524-b6af-edb7a6279faa"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]"], "manufacturer_name": ["Gland Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (68083-412-10)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE", "package_ndc": "68083-412-10", "marketing_start_date": "20250811"}], "brand_name": "Cangrelor", "product_id": "68083-412_706b6332-5afe-498b-a846-788e6ebc6823", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Decreased Platelet Aggregation [PE]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "68083-412", "generic_name": "Cangrelor", "labeler_name": "Gland Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cangrelor", "active_ingredients": [{"name": "CANGRELOR", "strength": "50 mg/1"}], "application_number": "ANDA213551", "marketing_category": "ANDA", "marketing_start_date": "20250811", "listing_expiration_date": "20261231"}